Description

Zecyte 250mg (Abiraterone Acetate 250mg) Tablets

Zecyte 250mg contains abiraterone acetate 250mg, an androgen biosynthesis inhibitor used in selected prostate cancer treatment plans. Cipla manufactures the product shown on this page.

Abiraterone reduces androgen production by inhibiting CYP17. Therefore, it can reduce hormonal stimulation of certain prostate cancer cells. Because the medicine can affect the liver, blood pressure, potassium levels, and adrenal function, patients need medical supervision during treatment.

What is Zecyte 250mg?

Zecyte 250mg is an oral tablet containing abiraterone acetate 250mg. The package shown here identifies Zecyte and Cipla.

Indian medicine listings identify Zecyte 250mg as abiraterone acetate 250mg and show a 120-tablet bottle.

Furthermore, abiraterone belongs to the androgen biosynthesis inhibitor class. It reduces the production of hormones that can support certain prostate cancer cells.

What Is Abiraterone?

Abiraterone acetate is converted in the body to abiraterone, the active compound that inhibits androgen production.

Androgens such as testosterone can stimulate prostate cancer growth. Consequently, reducing androgen production can help slow the growth of certain hormone-sensitive prostate cancers.

MedlinePlus describes abiraterone as an androgen biosynthesis inhibitor used with prednisone in specific advanced prostate cancer treatment settings.

Zecyte 250mg Uses

The main abiraterone prostate cancer uses involve advanced or metastatic disease.

• Selected metastatic castration-resistant prostate cancer
• Selected metastatic castration-sensitive prostate cancer
• Advanced prostate cancer treatment
• Hormonal treatment alongside androgen-deprivation therapy
• Combination treatment with an appropriate corticosteroid

Current U.S. labels include abiraterone acetate for specific metastatic prostate cancer settings. Therefore, an oncologist should determine whether the medicine fits a patient’s diagnosis and treatment history.

What Is Abiraterone Used For?

Abiraterone is used for certain advanced or metastatic prostate cancers.

In particular, treatment may target metastatic castration-resistant prostate cancer or selected metastatic castration-sensitive prostate cancer. The exact indication depends on the formulation and treatment plan.

As a result, patients should not use abiraterone for another condition without medical advice.

How Does Abiraterone Work?

Abiraterone inhibits an enzyme called CYP17. This enzyme plays an important role in androgen biosynthesis.

By reducing androgen production, the medicine lowers hormonal stimulation of prostate cancer cells. Consequently, certain prostate cancers may grow more slowly.

Abiraterone Mechanism of Action

The abiraterone mechanism of action involves inhibition of 17-alpha-hydroxylase and C17,20-lyase, which are activities of CYP17.

Abiraterone reduces androgen production from several sources, including the testes, adrenal glands, and prostate tumor tissue. Therefore, the medicine can provide broader androgen suppression within an appropriate treatment plan.

Current U.S. labeling identifies abiraterone acetate as a CYP17 inhibitor.

Abiraterone Drug Class

Abiraterone belongs to the androgen biosynthesis inhibitor class.

Unlike androgen-receptor blockers such as enzalutamide, abiraterone reduces androgen production itself. In contrast, enzalutamide mainly interferes with androgen-receptor signaling.

Zecyte 250mg Composition

• Active ingredient: Abiraterone acetate
• Strength: 250mg
• Dosage form: Tablet
• Brand: Zecyte
• Manufacturer/Marketer: Cipla
• Pack shown: 120 tablets

Abiraterone 250 mg Dose

The correct abiraterone dose depends on the formulation, cancer setting, corticosteroid regimen, and patient-specific factors.

For many standard abiraterone acetate tablet products in the United States, the recommended dose uses 1,000mg once daily. Four 250mg tablets can provide that total dose.

However, the 250mg tablet strength does not mean that every patient should take one tablet daily. Your oncologist must determine the appropriate total dose for your treatment.

Furthermore, different abiraterone formulations can have different dosing instructions. Always follow the prescribing information for the exact product you receive.

How Should Zecyte 250mg Be Taken?

Follow the prescription supplied by your oncology team. Standard abiraterone acetate tablets should generally be taken on an empty stomach.

For conventional abiraterone acetate tablets, current U.S. labeling instructs patients to avoid food for at least 2 hours before and 1 hour after the dose. Swallow the tablets whole with water.

Do not crush, chew, or alter the tablets unless a healthcare professional specifically instructs you to do so.

Importantly, some newer abiraterone formulations have different food instructions. Therefore, check the instructions for the exact product before use.

Abiraterone and Prednisone

Prednisone commonly accompanies standard abiraterone treatment.

The corticosteroid helps manage hormonal effects associated with CYP17 inhibition. Moreover, the exact corticosteroid and dose can depend on the abiraterone formulation and cancer setting.

For example, current U.S. labeling uses different prednisone schedules for different metastatic prostate cancer settings. Consequently, patients should follow the regimen prescribed by their oncology team.

Abiraterone and ADT

ADT means androgen deprivation therapy. Doctors may use abiraterone alongside ADT in appropriate prostate cancer treatment plans.

Current U.S. labeling for standard abiraterone acetate tablets specifies concurrent GnRH-analog therapy or previous bilateral orchiectomy in applicable treatment settings.

As a result, abiraterone often forms one part of a broader hormonal treatment strategy rather than acting as a stand-alone medicine.

Abiraterone Side Effects

Abiraterone side effects can vary between patients.

• Joint pain or swelling
• Hot flashes
• Diarrhea
• Constipation
• Heartburn
• Cough
• Fatigue
• High blood pressure
• Low potassium
• Fluid retention
• Muscle weakness

However, not every patient develops these effects. Tell your healthcare professional if a symptom becomes severe, persistent or unusual.

Serious Abiraterone Side Effects

Abiraterone can cause serious complications involving the liver, cardiovascular system, adrenal glands, and electrolytes.

For example, patients may develop high blood pressure, low potassium, or fluid retention. Therefore, doctors may monitor blood pressure, potassium levels, and symptoms during treatment.

Seek urgent medical attention for chest pain, severe shortness of breath, fainting, severe weakness, yellowing of the skin or eyes, dark urine, or an irregular heartbeat.

Abiraterone and Liver Problems

Abiraterone can cause liver injury. In severe cases, this complication can become life-threatening.

Consequently, doctors check liver function before treatment and continue laboratory monitoring during therapy.

Patients should report yellowing of the skin, dark urine, severe nausea, vomiting, or upper-right abdominal pain promptly.

Abiraterone and Blood Pressure

Abiraterone can increase mineralocorticoid activity. This effect may raise blood pressure.

Fluid retention can occur as well. Therefore, healthcare professionals may monitor blood pressure and swelling during treatment.

Patients with cardiovascular disease should discuss their medical history before starting therapy.

Abiraterone and Potassium

Low potassium can occur during abiraterone treatment.

Low potassium may contribute to muscle weakness or abnormal heart rhythms. For that reason, doctors monitor potassium levels during therapy.

Abiraterone and Fluid Retention

Some patients develop swelling in the feet, ankles, or legs.

Because significant fluid retention can affect cardiovascular health, report unusual swelling or sudden weight changes to your healthcare professional.

Abiraterone and Heart Problems

Patients with heart disease should tell their doctor before starting abiraterone.

Abiraterone-related blood-pressure changes, low potassium, and fluid retention can increase cardiovascular concerns. Accordingly, clinicians may monitor people with cardiovascular risk more closely.

Abiraterone vs Enzalutamide

Abiraterone and enzalutamide are both used in prostate cancer treatment, but they work through different pathways.

• Abiraterone: reduces androgen production by inhibiting CYP17.
• Enzalutamide: blocks androgen-receptor signaling.

Therefore, the two medicines are not simple substitutes. Treatment selection depends on disease stage, previous therapy, other medicines, and individual risk factors.

Abiraterone vs Apalutamide

Apalutamide directly targets the androgen receptor. Abiraterone, in contrast, reduces androgen production.

Both medicines can appear in prostate cancer treatment discussions. However, their approved uses and treatment combinations differ.

Abiraterone vs Darolutamide

Darolutamide acts on the androgen receptor, whereas abiraterone inhibits androgen biosynthesis.

Consequently, doctors consider different clinical factors when choosing between these medicines. The treatment plan should match the cancer stage and the patient’s overall health.

Abiraterone and Docetaxel

Docetaxel is a chemotherapy medicine, while abiraterone belongs to the hormonal therapy group.

Some prostate cancer treatment plans can include both types of therapy at different stages. Therefore, patients should follow the treatment plan created by their oncology team.

Abiraterone and Olaparib

Olaparib belongs to the PARP inhibitor class. Doctors may consider it for selected patients with specific molecular characteristics.

Abiraterone works through androgen suppression instead. As a result, the two medicines have different mechanisms and selection criteria.

Abiraterone and Niraparib

Niraparib is another PARP inhibitor that may appear in prostate cancer treatment discussions.

Its use depends on cancer characteristics and the applicable treatment strategy. Meanwhile, abiraterone targets androgen biosynthesis.

Abiraterone and Pluvicto

Pluvicto is a radioligand therapy used in selected advanced prostate cancer settings.

Abiraterone works through hormonal suppression instead. Therefore, these treatments can serve different roles during a patient’s treatment journey.

Abiraterone and Leuprolide

Leuprolide is an LHRH agonist that reduces testicular androgen production.

Doctors may combine leuprolide with abiraterone in appropriate treatment plans. In this combination, leuprolide reduces androgen production from the testes while abiraterone inhibits CYP17.

Abiraterone and Degarelix

Degarelix is a GnRH antagonist used as androgen deprivation therapy.

Because standard abiraterone treatment can require concurrent androgen deprivation, doctors may consider an appropriate GnRH-based therapy according to the patient’s treatment plan.

Abiraterone and Relugolix

Relugolix is an oral GnRH receptor antagonist that lowers testosterone production.

Abiraterone and relugolix act through different pathways. Therefore, the oncology team should determine whether their combination suits a particular patient.

Abiraterone and Denosumab

Denosumab can help manage certain bone-health concerns in selected patients with prostate cancer.

Abiraterone does not replace bone-directed therapy. Instead, clinicians may consider bone health separately according to cancer status, fracture risk, and treatment history.

Abiraterone Drug Interactions

Abiraterone can interact with other medicines. Therefore, provide your doctor with a complete medication list.

Include prescription medicines, over-the-counter products, vitamins, and herbal supplements. In particular, tell your healthcare professional about St. John’s wort before starting treatment.

Your doctor or pharmacist can review the list and identify medicines that may require additional monitoring.

Abiraterone and St. John’s Wort

St. John’s wort can interact with abiraterone.

Consequently, do not start this herbal supplement while taking abiraterone unless your healthcare professional approves it.

Who Should Tell Their Doctor Before Taking Abiraterone?

Tell your healthcare professional if you have:

• Liver disease
• Heart disease
• High blood pressure
• Low potassium
• Heart rhythm problems
• Adrenal problems
• Pituitary problems
• Diabetes
• Osteoporosis

Additionally, tell your doctor about previous heart problems, liver conditions, and all current medicines.

Abiraterone and Pregnancy

Abiraterone can harm a developing fetus. Therefore, people who are pregnant or may become pregnant should not take the medicine.

Importantly, people who are pregnant should not handle abiraterone tablets without appropriate protective gloves.

If pregnancy is possible during treatment, discuss effective contraception and pregnancy planning with a healthcare professional.

Abiraterone and Fertility

Abiraterone may affect male fertility.

People who have a partner who could become pregnant should discuss effective contraception with their healthcare professional.

Furthermore, anyone concerned about fertility should discuss fertility preservation before starting cancer treatment.

Abiraterone and Breastfeeding

People receiving abiraterone should discuss breastfeeding with their healthcare professional.

Current prescribing information advises against breastfeeding during treatment because of the potential for serious adverse effects in a breastfed child.

Therefore, discuss alternative feeding arrangements with the treating healthcare team before starting therapy.

What Happens If You Miss an Abiraterone Dose?

If you miss one dose, follow the instructions supplied with your specific product.

MedlinePlus advises taking the regular dose the following day after one missed dose. If more than one dose is missed, contact your doctor promptly.

Never take extra tablets to compensate for a missed dose unless your healthcare professional specifically instructs you to do so.

Can Abiraterone Be Stopped Suddenly?

Do not stop abiraterone or the accompanying corticosteroid without medical advice.

Because the medicine usually forms part of a larger treatment plan, sudden changes can affect the overall management strategy.

Instead, contact your oncology team if you have concerns about side effects or treatment duration.

How Long Does Abiraterone Treatment Last?

Treatment duration varies between patients.

Doctors may continue abiraterone while it provides appropriate clinical benefit and remains tolerable.

Regular visits help the oncology team assess PSA results, symptoms, laboratory findings, and disease response. Consequently, treatment duration can change according to clinical circumstances.

Abiraterone 250mg Price

Abiraterone 250mg price varies by brand, pharmacy, country, pack size, and prescription coverage.

Zecyte 250mg is a Cipla product supplied in a 120-tablet bottle. Prices can change over time, so verify the current price before purchase.

In addition, compare the exact strength, formulation, and pack size when reviewing prices.

Abiraterone Cost

Abiraterone cost depends on the manufacturer, formulation, pharmacy, and insurance or prescription coverage.

Generic availability can affect pricing significantly. Therefore, patients should compare equivalent products rather than comparing medicine names alone.

How Should Zecyte 250mg Be Stored?

Keep the tablets in their original container. Store the medicine according to the package instructions and protect it from excessive heat and moisture.

Additionally, keep Zecyte away from children and pets. Follow local pharmacy guidance when disposing of unused medicine.

Frequently Asked Questions About Zecyte 250mg

What is Zecyte 250mg used for?

Zecyte 250mg contains abiraterone acetate and can form part of treatment for selected advanced or metastatic prostate cancers.

What is the active ingredient in Zecyte 250mg?

The active ingredient is abiraterone acetate 250mg.

What is abiraterone used for?

Abiraterone is used in selected treatment plans for advanced or metastatic prostate cancer.

What is the abiraterone mechanism of action?

Abiraterone inhibits CYP17, an enzyme involved in androgen biosynthesis. As a result, androgen production decreases.

What is the usual abiraterone dose?

Many standard abiraterone acetate tablet regimens use 1,000mg once daily. Four 250mg tablets can provide that total dose. However, the correct dose depends on the specific product and treatment plan.

Is Zecyte 250mg the same as Zytiga?

Both products contain abiraterone acetate, but Zecyte and Zytiga are different brands. Therefore, patients should follow the prescribing information for the exact product they receive.

What are the common abiraterone side effects?

Possible effects include joint pain, hot flashes, diarrhea, constipation, high blood pressure, low potassium, and fluid retention.

Why is prednisone used with abiraterone?

Prednisone can help manage hormonal effects associated with CYP17 inhibition. The exact corticosteroid regimen depends on the abiraterone formulation and cancer setting.

Can abiraterone be taken with food?

Standard abiraterone acetate tablets should be taken on an empty stomach. Current U.S. labeling instructs patients to avoid food for at least 2 hours before and 1 hour after the dose.

Can abiraterone affect the liver?

Yes. Abiraterone can cause serious liver injury. Therefore, doctors monitor liver function during treatment.

Can abiraterone lower potassium?

Yes. Abiraterone can cause low potassium levels. For that reason, healthcare professionals may monitor potassium during therapy.

Is abiraterone chemotherapy?

No. Abiraterone is a hormonal cancer medicine that inhibits androgen biosynthesis rather than acting as traditional cytotoxic chemotherapy.

Can abiraterone be used with prednisone?

Yes. Prednisone commonly forms part of standard abiraterone treatment. However, the appropriate corticosteroid regimen depends on the specific product and cancer setting.

Can abiraterone affect blood pressure?

Yes. Abiraterone can increase blood pressure and contribute to fluid retention. Therefore, doctors may monitor blood pressure during treatment.

Can abiraterone cause fluid retention?

Yes. Abiraterone can cause swelling and fluid retention. Report significant swelling or sudden weight changes to your healthcare professional.

Can people who are pregnant take abiraterone?

No. Abiraterone can harm a developing fetus. Therefore, people who are pregnant or may become pregnant should not take the medicine.

Can abiraterone affect fertility?

Abiraterone may affect male fertility. People with fertility concerns should discuss these risks with their healthcare professional.

Is Zecyte 250mg FDA approved?

The image shows Zecyte 250mg, a Cipla product. This page does not represent the specific Zecyte brand as FDA-approved. U.S. approval applies to specific abiraterone acetate products and their approved labeling.

U.S. Medical Information

For U.S. medical information, consult authoritative resources from the National Library of Medicine and the U.S. Food and Drug Administration.

• DailyMed – Abiraterone Acetate
  
• MedlinePlus – Abiraterone
  
• FDA – Drugs and Medicines
  

Explore More Medicines

Explore additional prescription medicines and health products through our online medicine shop.

In addition, visit the IvermectinOnline.us homepage for more medicine information and product categories.

Important Regulatory Information

Zecyte 250mg shown on this page is a Cipla-branded abiraterone acetate product. The presence of this medicine on this website does not mean that the specific Zecyte brand or 250mg tablet has U.S. FDA approval.

Furthermore, U.S. abiraterone products can have different formulations, corticosteroid combinations, and dosing instructions. Therefore, patients should follow the prescribing information for the exact product they receive.

Medical Disclaimer

This page provides general educational information and does not replace advice from a qualified healthcare professional.

Zecyte 250mg contains a prescription cancer medicine that can cause serious adverse effects. For that reason, do not start, stop, or change treatment without guidance from an oncologist or another licensed healthcare professional.

Finally, patients should verify prescription requirements, product authenticity, regulatory status, importation rules, and dispensing requirements before obtaining or using this medicine.